A-36 Solution
NDC Package 58264-0328-1
Package Information
A-36 (bos taurus adrenal gland, agrimonia eupatoria, bellis perennis, camphor (natural), matricaria chamomilla, equisetum hyemale, fraxinus americana bark, formica rufa, histamine dihydrochloride, iodine, potassium dichromate, canis lupus familiaris milk, sodium chloride, anemone pulsatilla, salix nigra bark, and tobacco leaf) solution is a medication used as Constitutional treatment of inhalant allergies. This formulation utilizes a solution delivery system. Marketed by Dna Labs, Inc., this product is identified by NDC 58264-0328.
Identification & Billing
Clinical Specifications
- AGRIMONIA EUPATORIA 30 [hp_X]/mL
- ANEMONE PULSATILLA 4 [hp_X]/mL
- BELLIS PERENNIS 30 [hp_X]/mL
- BOS TAURUS ADRENAL GLAND 6 [hp_X]/mL
- CAMPHOR (NATURAL) 30 [hp_X]/mL
- CANIS LUPUS FAMILIARIS MILK 30 [hp_X]/mL
- EQUISETUM HYEMALE 6 [hp_X]/mL
- FORMICA RUFA 12 [hp_X]/mL
- FRAXINUS AMERICANA BARK 30 [hp_X]/mL
- HISTAMINE DIHYDROCHLORIDE 30 [hp_X]/mL
- IODINE 6 [hp_X]/mL
- MATRICARIA CHAMOMILLA 12 [hp_X]/mL
- POTASSIUM DICHROMATE 12 [hp_X]/mL
- SALIX NIGRA BARK 30 [hp_X]/mL
- SODIUM CHLORIDE 30 [hp_X]/mL
- TOBACCO LEAF 30 [hp_X]/mL
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 58264 - Dna Labs, Inc.
- 58264-0328 - A-36
- 58264-0328-1 - 29.57 mL in 1 BOTTLE, GLASS
- 58264-0328 - A-36
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 58264-0328-1 identifies a specific commercial package of 29.57 ml in 1 bottle, glass of A-36, a human over the counter drug labeled by Dna Labs, Inc.. This solution is formulated for sublingual use and contains agrimonia eupatoria; anemone pulsatilla; bellis perennis; bos taurus adrenal gland; camphor (natural); canis lupus familiaris milk; equisetum hyemale; formica rufa; fraxinus americana bark; histamine dihydrochloride; iodine; matricaria chamomilla; potassium dichromate; salix nigra bark; sodium chloride; tobacco leaf as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dna Labs, Inc. on January 01, 1990. The current certification is valid through December 31, 2026.
How is this Dna Labs, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 58264032801. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.